Clinical Trial for Convalescent Serum Therapy to Treat COVID-19
Lifespan/Brown University has been included in the first round of sites selected for the CSSC-001 and CSSC-004 convalescent plasma studies being run by Johns Hopkins University. Lead by Adam Levine (Site PI), Lifespan/Brown was selected as one of the first 10 sites for two major protocols: (1) post exposure prophylaxis and (2) mild outpatient disease.